Test-and-treat strategy for Helicobacter pylori (HP) infection in older patients

Archives of Gerontology and Geriatrics

Volumn 51, Issue 3, 2010, Pages 237-240

  Rotolo, G ^a   Dominguez, L J ^a   Sarakatsianou, V ^a   Mangiaracina, D ^a   Figlioli, F ^a   Barbagallo, M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dyspepsia in aging; Helicobacter pylori; Test and treat

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ABDOMINAL PAIN; AGED; AGING; ANTIBIOTIC THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HAIRY TONGUE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UREA BREATH TEST; VOMITING;

AGED; BREATH TESTS; CHI-SQUARE DISTRIBUTION; DYSPEPSIA; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE;

HELICOBACTER PYLORI;

EID: 77957378101     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.11.006     Document Type: Article

References (26)

1. Abdalla A.M., Sordillo E.M., Hanzely Z., Perez-Perez G.I., Blaser M.J., Holt P.R., Moss S.F. Insensitivity of the CLOtest for H. pylori, especially in the elderly. Gastroenterology 1998, 115:243-244.
2. Bank L., Wright J.P., Lucke W., Marks I.N. Peptic ulcer. A follow-up study. J. Clin. Gastroenterol. 1986, 8:381-384.
3. Catalano F., Branciforte G., Brogna A., Bentivegna C., Luca S., Terranova R., Michalos A., Dawson B.K., Chodash H.B. Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments. Dig. Dis. Sci. 1999, 44:863-867.
4. Chan F.K., Chung S.C., Suen B.Y., Lee Y.T., Leung W.K., Leung V.K., Wu J.C., Lau J.Y., Hui Y., Lai M.S., Chan H.L., Sung J.J. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N. Engl. J. Med. 2001, 344:967-973.
5. De Bortoli N., Leonardi G., Ciancia E., Merlo A., Bellini M., Costa F., Mumolo M.G., Ricchiuti A., Cristiani F., Santi S., Rossi M., Marchi S. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am. J. Gastroenterol. 2007, 102:951-956.
6. Fukase K., Kato M., Kikuchi S., Inoue K., Uemura N., Okamoto S., Terao S., Amagai K., Hayashi S., Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008, 372:392-397.
7. Hood H.M., Wark C., Burgess P.A., Nicewander D., Scott M.W. Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in medicare patients hospitalized with peptic ulcer disease. Arch. Intern. Med. 1999, 159:149-154.
8. Lassen A.T., Pedersen F.M., Bytzer P., Schaffalitzky de Muckadell O.B. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000, 356:455-460.
9. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E.J. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
10. Moshkowitz M., Brill S., Konikoff F.M., Reif S., Arber N., Halpern Z. The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia. J. Am. Geriatr. Soc. 1999, 47:720-722.
11. Nervi G., Liatopoulou S., Cavallaro L.G., Gnocchi A., Dal-Bo N., Rugge M., Iori V., Cavestro G.M., Maino M., Colla G., Franze A., Di Mario F. Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey. World J. Gastroenterol. 2006, 12:2398-2401.
12. Ofman J.J., Etchason J., Alexander W., Stevens B.R., Herrin J., Cangialose C., Ballard D.J., Bratzler D., Elward K.S., FitzGerald D., Culpepper-Morgan J., Marshall B. The quality of care for Medicare patients with peptic ulcer disease. Am. J. Gastroenterol. 2000, 95:106-113.
13. Pilotto A. Aging and the gastrointestinal tract. Ital. J. Gastroenterol. Hepatol. 1999, 31:137-153.
14. Pilotto A., Malfertheiner P. Review article: an approach to Helicobacter pylori infection in the elderly. Aliment. Pharmacol. Ther. 2002, 16:683-691.
15. Pilotto A., Di Mario F., Franceschi M., Scagnelli M., Soffiati F., Di Mario F., Fortunato A., Valerio G. Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. Aliment. Pharmacol. Ther. 1996, 10:1021-1027.
16. Pilotto A., Franceschi M., Di Mario F., Leandro G., Bozzola L., Valerio G. The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease. Gerontology 1998, 44:153-158.
17. Pilotto A., Leandro G., Franceschi M., Bozzola L., Fortunato A., Rassu M., Meli S., Soffiati G., Scagnelli M., Di Mario F., Valerio G. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment. Pharmacol. Ther. 1999, 13:667-673.
18. Pilotto A., Di Mario F., Franceschi M., Leandro G., Battaglia G., Germana B., Marin R., Valerio G. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Aliment. Pharmacol. Ther. 2000, 14:1077-1082.
19. Pilotto A., Franceschi M., Costa M.C., Di Mario F., Valerio G. Helicobacter pylori test-and-eradication strategy. Lancet 2000, 356:1683-1684.
20. 13C-urea breath test with serology. J. Gerontol. A: Biol. Sci. Med. Sci. 2000, 55:M163-M167.
21. Regev A., Fraser G.M., Braun M., Maoz E., Leibovici L., Niv Y. Seroprevalence of Helicobacter pylori and length of stay in a nursing home. Helicobacter 1999, 4:89-93.
22. Roll J., Weng A., Newman J. Diagnosis and treatment of Helicobacter pylori infection among California Medicare patients. Arch. Intern. Med. 1997, 157:994-998.
23. Sung J.J., Lin S.R., Ching J.Y., Zhou L.Y., To K.F., Wang R.T., Leung W.K., Ng E.K., Lau J.Y., Lee Y.T., Yeung C.K., Chao W., Chung S.C. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000, 119:7-14.
24. Take S., Mizuno M., Ishiki K., Nagahara Y., Yoshida T., Yokota K., Oguma K. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J. Gastroenterol. 2007, 42(Suppl. 17):21-27.
25. Talley N.J., Fock K.M., Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am. J. Gastroenterol. 2008, 103:510-514.
26. Vaira D., Zullo A., Vakil N., Gatta L., Ricci C., Perna F., Hassan C., Bernabucci V., Tampieri A., Morini S. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann. Intern. Med. 2007, 146:556-563.